[QODLink]
Tennis

Berdych tames Cilic for Rotterdam title

Tomas Berdych wins 1st ATP title since October 2012, beating Marin Cilic 6-4, 6-2 in the Rotterdam final.

Last updated: 16 Feb 2014 16:20
Email Article
Print Article
Share article
Send Feedback
Tomas Berdych last won an ATP tournament in October 2012 [Reuters]

Tomas Berdych has won his first ATP tournament title since October 2012, beating Marin Cilic of Croatia 6-4, 6-2 in the ABN Amro final.

The third-seeded Czech survived a 10-minute service game in the first set where Cilic had three chances to break. Berdych remained calm and held serve, then broke Cilic in the following game as the Croat hit a return into the net.

In the second set Berdych's serve was increasingly strong, prompting Cilic to throw his racket into the air in frustration after one lost point.

Cilic came into the match having won a tournament last week in Zagreb and ousting two top-10 players in Rotterdam - Jo-Wilfried Tsonga and Andy Murray - on his way to the final.

114

Source:
AP
Email Article
Print Article
Share article
Send Feedback
Topics in this article
People
Country
City
Featured on Al Jazeera
Italy struggles to deal with growing flood of migrants willing to risk their lives to reach the nearest European shores.
Israel's Operation Protective Edge is the third major offensive on the Gaza Strip in six years.
Muslims and Arabs in the US say they face discrimination in many areas of life, 13 years after the 9/11 attacks.
At one UN site alone, approximately four children below the age of five are dying each day.
Featured
'I'm dying anyway, one piece at a time' said Steve Fobister, who suffers from disabilities caused by mercury poisoning.
The world's newest professional sport comes from an unlikely source: video games.
The group's takeover of farms in Qaraqosh, 30km from Mosul, has caused fear among residents, and a jump in food prices.
Protests and online activism in recent months have brought a resurgence of ethnic Oromo nationalism in Ethiopia.
Chemotherapy is big business, but some US doctors say it could be overused and are pushing for cheaper and better care.
join our mailing list